Immunochemotherapy in patients with non-squamous lung cancer

被引：0

作者：

Pluzanski, Adam ^{[1
,2
]}

Piorek, Aleksandra ^{[1
]}

机构：

[1] Maria Skodowska Curie Natl Res Inst Oncol, Dept Lung & Chest Canc, Warsaw, Poland

[2] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Lung & Chest Canc, Ul Roentgena 5, PL-02781 Warsaw, Poland

来源：

ONCOLOGY IN CLINICAL PRACTICE | 2024年 / 20卷 / 06期

关键词：

immunotherapy; chemotherapy; non-small-cell lung cancer; OPEN-LABEL; CHEMOTHERAPY; PEMBROLIZUMAB; PLATINUM;

D O I：

10.5603/ocp.97614

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immunochemotherapy is one of the main treatment options in patients with non-squamous non-small -cell lung cancer without molecular targeted abnormalities. In Poland, immunotherapy given concurrently with chemotherapy is available in patients with programmed death ligand 1 (PD -L1) expression below 50%. Pembrolizumab plus chemotherapy and nivolumab with ipilimumab with 2 cycles of chemotherapy are more efficient than chemotherapy alone with longer progression -free survival (PFS) and overall survival (OS). Other immunochemotherapy regimens including atezolizumab, durvalumab, tremelimumab, or cemiplimab are not used in daily practice in Poland. Benefits observed with immunochemotherapy are limited to patients in Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 and without contraindications to immune checkpoint inhibitors and cytotoxic agents.

引用

页码：415 / 419

页数：5

共 15 条

[1] Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study [J].

Gadgeel, Shirish M. ;

Stevenson, James P. ;

Langer, Corey J. ;

Gandhi, Leena ;

Borghaei, Hossein ;

Patnaik, Amita ;

Villaruz, Liza C. ;

Gubens, Matthew ;

Hauke, Ralph ;

Yang, James Chih-Hsin ;

Sequist, Lecia V. ;

Bachman, Robert ;

Saraf, Sanatan ;

Raftopoulos, Harry ;

Papadimitrakopoulou, Vassiliki .

LUNG CANCER, 2018, 125 :273-281

[2] Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents [J].

Galluzzi, Lorenzo ;

Buque, Aitziber ;

Kepp, Oliver ;

Zitvogel, Laurence ;

Kroemer, Guido .

CANCER CELL, 2015, 28 (06) :690-714

[3] Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer [J].

Gandhi, L. ;

Rodriguez-Abreu, D. ;

Gadgeel, S. ;

Esteban, E. ;

Felip, E. ;

De Angelis, F. ;

Domine, M. ;

Clingan, P. ;

Hochmair, M. J. ;

Powell, S. F. ;

Cheng, S. Y. -S. ;

Bischoff, H. G. ;

Peled, N. ;

Grossi, F. ;

Jennens, R. R. ;

Reck, M. ;

Hui, R. ;

Garon, E. B. ;

Boyer, M. ;

Rubio-Viqueira, B. ;

Novello, S. ;

Kurata, T. ;

Gray, J. E. ;

Vida, J. ;

Wei, Z. ;

Yang, J. ;

Raftopoulos, H. ;

Pietanza, M. C. ;

Garassino, M. C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2078-2092

[4] Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study [J].

Garassino, Marina C. ;

Gadgeel, Shirish ;

Speranza, Giovanna ;

Felip, Enriqueta ;

Esteban, Emilio ;

Domine, Manuel ;

Hochmair, Maximilian J. ;

Powell, Steven F. ;

Bischoff, Helge G. ;

Peled, Nir ;

Grossi, Francesco ;

Jennens, Ross R. ;

Reck, Martin ;

Hui, Rina ;

Garon, Edward B. ;

Kurata, Takayasu ;

Gray, Jhanelle E. ;

Schwarzenberger, Paul ;

Jensen, Erin ;

Pietanza, M. Catherine ;

Rodriguez-Abreu, Delvys .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (11) :1992-+

[5] Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial [J].

Gogishvili, Miranda ;

Melkadze, Tamar ;

Makharadze, Tamta ;

Giorgadze, Davit ;

Dvorkin, Mikhail ;

Penkov, Konstantin ;

Laktionov, Konstantin ;

Nemsadze, Gia ;

Nechaeva, Marina ;

Rozhkova, Irina ;

Kalinka, Ewa ;

Gessner, Christian ;

Moreno-Jaime, Brizio ;

Passalacqua, Rodolfo ;

Li, Siyu ;

McGuire, Kristina ;

Kaul, Manika ;

Paccaly, Anne ;

Quek, Ruben G. W. ;

Gao, Bo ;

Seebach, Frank ;

Weinreich, David M. ;

Yancopoulos, George D. ;

Lowy, Israel ;

Gullo, Giuseppe ;

Rietschel, Petra .

NATURE MEDICINE, 2022, 28 (11) :2374-+

[6] Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study [J].

Johnson, Melissa L. ;

Cho, Byoung Chul ;

Luft, Alexander ;

Alatorre-Alexander, Jorge ;

Geater, Sarayut Lucien ;

Laktionov, Konstantin ;

Kim, Sang-We ;

Ursol, Grygorii ;

Hussein, Maen ;

Lim, Farah Louise ;

Yang, Cheng-Ta ;

Araujo, Luiz Henrique ;

Saito, Haruhiro ;

Reinmuth, Niels ;

Shi, Xiaojin ;

Poole, Lynne ;

Peters, Solange ;

Garon, Edward B. ;

Mok, Tony .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (06) :1213-+

[7] Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study [J].

Langer, Corey J. ;

Gadgeel, Shirish M. ;

Borghaei, Hossein ;

Papadimitrakopoulou, Vassiliki A. ;

Patnaik, Amita ;

Powell, Steven F. ;

Gentzler, Ryan D. ;

Martins, Renato G. ;

Stevenson, James P. ;

Jalal, Shadia I. ;

Panwalkar, Amit ;

Yang, James Chih-Hsin ;

Gubens, Matthew ;

Sequist, Lecia V. ;

Awad, Mark M. ;

Fiore, Joseph ;

Ge, Yang ;

Raftopoulos, Harry ;

Gandhi, Leena .

LANCET ONCOLOGY, 2016, 17 (11) :1497-1508

[8] Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 Trial [J].

Makharadze, Tamta ;

Gogishvili, Miranda ;

Melkadze, Tamar ;

Baramidze, Ana ;

Giorgadze, Davit ;

Penkov, Konstantin ;

Laktionov, Konstantin ;

Nemsadze, Gia ;

Nechaeva, Marina ;

Rozhkova, Irina ;

Kalinka, Ewa ;

Li, Siyu ;

Li, Yuntong ;

Kaul, Manika ;

Quek, Ruben G. W. ;

Poulio, Jean-Francois ;

Seebach, Frank ;

Lowy, Israel ;

Gullo, Giuseppe ;

Rietschel, Petra .

JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (06) :755-768

[9] IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain [J].

Nogami, Naoyuki ;

Barlesi, Fabrice ;

Socinski, Mark A. ;

Reck, Martin ;

Thomas, Christian A. ;

Cappuzzo, Federico ;

Mok, Tony S. K. ;

Finley, Gene ;

Aerts, Joachim G. ;

Orlandi, Francisco ;

Moro-Sibilot, Denis ;

Jotte, Robert M. ;

Stroyakovskiy, Daniil ;

Villaruz, Liza C. ;

Rodriguez-Abreu, Delvys ;

Lim, Darren Wan-Teck ;

Merritt, David ;

Coleman, Shelley ;

Lee, Anthony ;

Shankar, Geetha ;

Yu, Wei ;

Bara, Ilze ;

Nishio, Makoto .

JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (02) :309-323

[10] First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial [J].

Paz-Ares, Luis ;

Ciuleanu, Tudor-Eliade ;

Cobo, Manuel ;

Schenker, Michael ;

Zurawski, Bogdan ;

Menezes, Juliana ;

Richardet, Eduardo ;

Bennouna, Jaafar ;

Felip, Enriqueta ;

Juan-Vidal, Oscar ;

Alexandru, Aurelia ;

Sakai, Hiroshi ;

Lingua, Alejo ;

Salman, Pamela ;

Souquet, Pierre-Jean ;

De Marchi, Pedro ;

Martin, Claudio ;

Perol, Maurice ;

Scherpereel, Arnaud ;

Lu, Shue ;

John, Thomas ;

Carbone, David P. ;

Meadows-Shropshire, Stephanie ;

Agrawal, Shruti ;

Oukessou, Abderrahim ;

Yan, Jinchun ;

Reck, Martin .

LANCET ONCOLOGY, 2021, 22 (02) :198-211

← 1 2 →